Aethlon Medical (AEMD) Net Shares Issued and Repurchased (2013 - 2026)

Aethlon Medical (AEMD) has reported Net Shares Issued and Repurchased for 14 consecutive years, with $22793.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 631.48% year-over-year to $22793.0; the trailing twelve-month figure through Mar 2026 stood at $22793.0 (up 631.48% YoY), and the FY2026 full-year result was $22793.0, up 631.48% from the prior year.
• Net Shares Issued and Repurchased declined to $22793.0 in Q1 2026 per AEMD's latest filing, from $71432.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $266888.0 in Q2 2022 and bottomed at $3116.0 in Q1 2025.
• Historically, Net Shares Issued and Repurchased has averaged $61449.1 across 5 years, with a median of $22793.0 in 2026.
• The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased tumbled 96.97% in 2022, then surged 754.39% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $266888.0 in 2022, then plunged by 94.23% to $15400.0 in 2023, then soared by 754.39% to $131576.0 in 2024, then plunged by 45.71% to $71432.0 in 2025, then sank by 68.09% to $22793.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $22793.0, $71432.0, and $3116.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.